Literature DB >> 32487735

Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Lloyd D Fricker1, Elyssa B Margolis2, Ivone Gomes2, Lakshmi A Devi2.   

Abstract

In the mid-1970s, an intense race to identify endogenous substances that activated the same receptors as opiates resulted in the identification of the first endogenous opioid peptides. Since then, >20 peptides with opioid receptor activity have been discovered, all of which are generated from three precursors, proenkephalin, prodynorphin, and proopiomelanocortin, by sequential proteolytic processing by prohormone convertases and carboxypeptidase E. Each of these peptides binds to all three of the opioid receptor types (μ, δ, or κ), albeit with differing affinities. Peptides derived from proenkephalin and prodynorphin are broadly distributed in the brain, and mRNA encoding all three precursors are highly expressed in some peripheral tissues. Various approaches have been used to explore the functions of the opioid peptides in specific behaviors and brain circuits. These methods include directly administering the peptides ex vivo (i.e., to excised tissue) or in vivo (in animals), using antagonists of opioid receptors to infer endogenous peptide activity, and genetic knockout of opioid peptide precursors. Collectively, these studies add to our current understanding of the function of endogenous opioids, especially when similar results are found using different approaches. We briefly review the history of identification of opioid peptides, highlight the major findings, address several myths that are widely accepted but not supported by recent data, and discuss unanswered questions and future directions for research. SIGNIFICANCE STATEMENT: Activation of the opioid receptors by opiates and synthetic drugs leads to central and peripheral biological effects, including analgesia and respiratory depression, but these may not be the primary functions of the endogenous opioid peptides. Instead, the opioid peptides play complex and overlapping roles in a variety of systems, including reward pathways, and an important direction for research is the delineation of the role of individual peptides.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32487735      PMCID: PMC7330675          DOI: 10.1124/mol.120.119388

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  130 in total

1.  Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain.

Authors:  J D Levine; N C Gordon; H L Fields
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior.

Authors:  M Cador; A E Kelley; M Le Moal; L Stinus
Journal:  Neuroscience       Date:  1986-07       Impact factor: 3.590

Review 4.  A Test in Context: Neprilysin: Function, Inhibition, and Biomarker.

Authors:  Antoni Bayes-Genis; Jaume Barallat; A Mark Richards
Journal:  J Am Coll Cardiol       Date:  2016-08-09       Impact factor: 24.094

5.  A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.

Authors:  G Henderson; J Hughes; H W Kosterlitz
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

Review 6.  Type I signal peptidase: an overview.

Authors:  Renu Tuteja
Journal:  Arch Biochem Biophys       Date:  2005-09-15       Impact factor: 4.013

7.  Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.

Authors:  A Gupta; W Fujita; I Gomes; E Bobeck; L A Devi
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.

Authors:  A Alt; A Mansour; H Akil; F Medzihradsky; J R Traynor; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

10.  Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats.

Authors:  Sarah Page; Maria M Mavrikaki; Tania Lintz; Daniel Puttick; Edward Roberts; Hugh Rosen; F Ivy Carroll; William A Carlezon; Elena H Chartoff
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

View more
  27 in total

1.  Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq.

Authors:  Sara E Vazquez; Sabrina A Mann; Aaron Bodansky; Andrew F Kung; Zoe Quandt; Elise M N Ferré; Nils Landegren; Daniel Eriksson; Paul Bastard; Shen-Ying Zhang; Jamin Liu; Anthea Mitchell; Caleigh Mandel-Brehm; Brenda Miao; Gavin Sowa; Kelsey Zorn; Alice Y Chan; Chisato Shimizu; Adriana Tremoulet; Kara Lynch; Michael R Wilson; Olle Kampe; Kerry Dobbs; Ottavia M Delmonte; Luigi D Notarangelo; Jane C Burns; Jean-Laurent Casanova; Michail S Lionakis; Troy R Torgerson; Mark S Anderson; Joseph L DeRisi
Journal:  bioRxiv       Date:  2022-03-24

2.  GPR83 engages endogenous peptides from two distinct precursors to elicit differential signaling.

Authors:  Seshat M Mack; Ivone Gomes; Amanda K Fakira; Mariana L Duarte; Achla Gupta; Lloyd Fricker; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2022-05-23       Impact factor: 4.054

3.  Challenges and new opportunities for detecting endogenous opioid peptides in reward.

Authors:  Sineadh M Conway; Marwa O Mikati; Ream Al-Hasani
Journal:  Addict Neurosci       Date:  2022-04-03

Review 4.  Signaling mechanisms of μ-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation.

Authors:  Min-Ho Nam; Woojin Won; Kyung-Seok Han; C Justin Lee
Journal:  Cell Mol Life Sci       Date:  2020-07-15       Impact factor: 9.261

5.  Pro-Enkephalin and its association with renal function in Middle Eastern immigrants and native Swedes.

Authors:  Christopher Nilsson; Anders Christensson; Peter M Nilsson; Olle Melander; Louise Bennet
Journal:  Scand J Clin Lab Invest       Date:  2021-09-28       Impact factor: 1.713

6.  Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.

Authors:  Catherine Cahill; Hugo A Tejeda; Mariana Spetea; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Neuropeptidomic Analysis of a Genetically Defined Cell Type in Mouse Brain and Pituitary.

Authors:  Lloyd D Fricker; Alexandre K Tashima; Amanda K Fakira; Ute Hochgeschwender; William C Wetsel; Lakshmi A Devi
Journal:  Cell Chem Biol       Date:  2020-11-19       Impact factor: 8.116

Review 8.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

Review 9.  From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks.

Authors:  Nikolai Jaschke; Sophie Pählig; Ying-Xian Pan; Lorenz C Hofbauer; Andy Göbel; Tilman D Rachner
Journal:  Trends Endocrinol Metab       Date:  2021-03-03       Impact factor: 12.015

10.  Regulation of Opioid Receptors by Their Endogenous Opioid Peptides.

Authors:  Achla Gupta; Srinivas Gullapalli; Hui Pan; Dinah L Ramos-Ortolaza; Michael D Hayward; Malcom J Low; John E Pintar; Lakshmi A Devi; Ivone Gomes
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.